Related Experiment Video

Updated: Aug 25, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.4K

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures

Ciara S McNevin1,2, Karen Cadoo2,3, Anne-Marie Baird3

  • 1Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, D08 W9RT Dublin, Ireland.

Cancers
|October 14, 2022
PubMed

Insights

Poly (ADP-ribose) polymerase inhibitors show promise in treating metastatic castrate-resistant prostate cancer (mCRPC). Research is expanding to include non-BRCA DNA damage signatures for improved precision medicine in mCRPC.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Metastatic castrate-resistant prostate cancer (mCRPC) treatment has advanced, yet it remains a lethal disease with lagging precision medicine.
  • Poly (ADP-ribose) polymerase inhibitors (PARPi) are a key therapeutic class, with initial studies focusing on BRCA1/2 mutations.

Purpose of the Study:

  • To review the literature on PARPi efficacy in mCRPC.
  • To explore PARPi activity in both BRCA-mutated and non-BRCA tumors exhibiting DNA damage signatures.

Main Methods:

  • Literature review of studies on PARPi in prostate cancer.
  • Analysis of clinical data and preclinical research on homologous recombination deficiency (HRD) and DNA damage repair (DDR) genes.

Main Results:

  • PARPi have demonstrated efficacy in mCRPC, particularly in tumors with BRCA1/2 mutations.
  • Emerging evidence suggests potential efficacy of PARPi in mCRPC with non-BRCA DNA damage signatures, indicating broader applicability.

Conclusions:

  • PARPi represent a significant therapeutic option for mCRPC.
  • Further investigation into non-BRCA DNA damage signatures is crucial for expanding precision medicine strategies in mCRPC treatment.
Keywords:
BRCAPARP inhibitorshomologous recombination repairmetastatic castrate resistant prostate cancer

More Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.8K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.1K

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K